Skip to main content

Table 1 Demographic features of subjects enrolled in the study

From: Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study

 

PF Tafluprost 0.0015% group

PF Timolol 0.1% group

Control group

Patients

27

24

20

Eyes

54

48

40

Age (years)

65.11 ± 10.16

65.08 ± 10.79

64.85 ± 9.76

Gender (male/female)

15/12

13/11

12/8

Diagnosis

54POAG

46POAG/2OH

/

Treatment Duration (months)

42.93 ± 6.04

44.38 ± 8.22

-

IOP (mmHg)

16.61 ± 2.01

16.31 ± 2.86

14.50 ± 1.93

  1. Age, treatment duration and IOP are expressed by mean ± standard deviation
  2. PF preservative free, IOP intraocular pressure